Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae

Infection and Immunity

Volumn 68, Issue 6, 2000, Pages 3635-3641

  Rödel, Jürgen ^a   Woytas, Marcus ^a   Groh, Annemarie ^a   Schmidt, Karl Hermann ^a   Hartmann, Matthias ^a   Lehmann, Marc ^a   Straube, Eberhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR A;

ARTICLE; ATHEROSCLEROSIS; BACTERIAL INFECTION; BACTERIUM CULTURE; CHLAMYDOPHILA PNEUMONIAE; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER;

ARTERIOSCLEROSIS; ASTHMA; BRONCHI; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; FIBROBLAST GROWTH FACTOR 2; IMMUNOASSAY; INTERLEUKIN-6; MUSCLE, SMOOTH; PLATELET-DERIVED GROWTH FACTOR; SPECIES SPECIFICITY;

EID: 0141624402     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.6.3635-3641.2000     Document Type: Article

References (41)

1. Bonner, J. C., A. Badgett, P. M. Lindroos, and P. G. Coin. 1996. Basic fibroblast growth factor induces expression of the PDGF receptor-α on human bronchial smooth muscle cells. Am. J. Physiol. 271:L880-L888.
2. Chanez, P., M. Vignola, R. Stenger, P. Vic, F. B. Michel, and J. Bousquet. 1995. Platelet-derived growth factor in asthma. Allergy 50:878-883.
3. Cook, P. J., P. Davies, W. Tunnicliffe, J. G. Ayres, D. Honeybourne, and R. Wise. 1998. Chlamydia pneumoniae and asthma. Thorax 53:254-259.
4. Coombs, B. K., and J. B. Mahony. 1999. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial-derived soluble factor(s). Infect. Immun. 67:2909-2915.
5. Cucina, A., S. Pagliei, V. Borrelli, V. Corvino, F. Stipa, A. Cavallaro, and A. V. Sterpetti. 1998. Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells. Eur. J. Vasc. Endovasc. Surg. 16:197-202.
6. Davis, M. G., M. Zhou, S. Ali, J. D. Coffin, T. Doetschman, and G. W. Dorn II. 1997. Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J. Mol. Cell. Cardiol. 29:1061-1072.
7. De, S., E. T. Zelazny, J. F. Souhrada, and M. Souhrada. 1995. IL-1β and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. J. Appl. Physiol. 78:1555-1563.
8. Dechend, R., M. Maass, J. Gieffers, R. Dietz, C. Scheidereit, A. Leutz, and D. C. Gulba. 1999. Chlamydia pneumoniae infection of vascular smooth muscle cells and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression. Circulation 100:1369-1373.
9. Everett, K. D. E., R. M. Bush, and A. A. Andersen. 1999. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov., and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int. J. Syst. Bacteriol. 49:415-440.
10. Fan, Y., S. Wang, and X. Yang. 1999. Chlamydia trachomatis (mouse pneumonitis strain) induces cardiovascular pathology following respiratory tract infection. Infect. Immun. 67:6145-6151.
11. Gibbs, R. G. J., N. Carey, and A. H. Davies. 1998. Chlamydia pneumoniae and vascular disease. Br. J. Surg. 85:1191-1197.
12. Grayston, J. T., and L. A. Campbell. 1999. The role of Chlamydia pneumoniae in atherosclerosis. Clin. Infect. Dis. 28:993-994.
13. Hahn, D. L. 1996. Intracellular pathogens and their role in asthma: Chlamydia pneumoniae in adult patients. Eur. Respir. Rev. 6:224-230.
14. Hahn, D. L., D. Bukstein, A. Luskin, and H. Zeitz. 1998. Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. Ann. Allergy Asthma Immunol. 80:45-49.
15. Hahn, D. L., and R. McDonald. 1998. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann. Allergy Asthma Immunol. 81:339-344.
16. Heinemann, M., M. Susa, U. Simnacher, R. Marre, and A. Essig. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64:4872-4875.
17. Hirst, S. J. 1996. Airway smooth muscle cell culture: application to studies of airway remodelling and phenotype plasticity. Eur. Respir. J. 9:808-820.
18. Ikeda, U., M. Ikeda, T. Oahara, A. Oguchi, T. Kamitani, Y. Tsuruya, and S. Kano. 1991. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am. J. Physiol. 260:H1713-H1717.
19. Kennedy, S. H., S. Ronda, H. Qin, S. Aho, J. Selber, and E. M. L. Tan. 1997. Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells. J. Cell. Biochem. 65:32-41.
20. Knoebel, E., P. Vijayagopal, J. E. Figueroa II, and D. H. Martin. 1997. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect. Immun. 65:503-506.
21. Kol, A., T. Bourcier, A. H. Lichtmann, and P. Libby. 1999. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J. Clin. Investig. 103:571-577.
22. Kotake, S., H. R. Schumacher, Jr., and R. L. Wilder. 1996. A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples. J. Immunol. Methods 199:193-203.
23. Lambert, D., C. L. Eaton, and B. J. Harrison. 1998. Fibroblast growth factors and their receptors in parathyroid disease. World J. Surg. 22:520-525.
24. Maass, M., C. Bartels, P. M. Engel, U. Mamat, and H. H. Sievers. 1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31:827-832.
25. Molestina, R. E., D. Dean, R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells. Infect. Immun. 66:1370-1376.
26. Molestina, R. E., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1999. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect. Immun. 67:1323-1330.
27. Pai, J., F. C. Knoop, and W. J. Hunter III. 1998. Chlamydia pneumoniae and occlusive vascular disease: identification and characterization. J. Pharmacol. Toxicol. Methods 39:51-61.
28. Palmer, H., and P. Libby. 1992. Interferon-β: a potential autocrine regulator of human vascular smooth muscle cell growth. Lab. Investig. 66:715-721.
29. Ramirez, J. A. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann. Intern. Med. 125:979-982.
30. Rasmussen, S. J., L. Eckmann, A. J. Quayle, L. Schen, Y.-X. Zhang, D. J. Anderson, J. Fierer, R. S. Stephens, and M. F. Kagnoff. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Investig. 99:77-87.
31. Redinglon, A. E., and P. H. Howarth. 1997. Airway remodelling in asthma. Thorax 52:310-312.
32. Reidy, M. A. 1994. Growth factors and arterial smooth muscle cell proliferation. Ann. N. Y. Acad. Sci. 714:225-230.
33. Roberts, C. R. 1995. Is asthma a fibrotic disease? Chest Suppl. 107(Suppl.): 111S-117S.
34. Rödel, J., A. Groh, M. Hartmann, K.-H. Schmidt, M. Lehmann, W. Lungershausen, and E. Straube. 1999. Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts. Med. Microbiol. Immunol. 187:205-212.
35. Rolfs, A., I. Schuller, U. Finckh, and I. Weber-Rolfs. 1992. PCR: clinical diagnostics and research, p. 102-107. Springer-Verlag, Berlin, Germany.
36. Virchow, J. C., Jr., C. Kroegel, C. Walker, and H. Matthys. 1996. Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J. Allergy Clin. Immunol. 98:S27-S33.
37. von Hertzen, L., M. Töyrylä, A. Gimishanov, A. Bloigu, M. Leinonen, P. Saikku, and T. Haahtela. 1999. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin. Exp. Allergy 29:522-528.
38. Wang, A. M., M. V. Doyle, and D. F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:9717-9721.
39. Yamashita, K., K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa, and H. Ito. 1998. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29:773-778.
40. Yazdani, S., A. D. Simon, R. Vidhun, C. Gulotta, A. Schwartz, and L. E. Rabbani. 1998. Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. Am. Heart J. 136:357-361.
41. Yokoyama, A., N. Kohno, S. Fujino, H. Hamada, Y. Inone, S. Fujioka, S. Ishida, and K. Hiwada. 1995. Circulating interleukin-6 levels in patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 151:1354-1358.